Tohid Kazemi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Positive Breast Cancer

Helicobacter Pylori

Cell Proliferation

Top Venues

Journal of cellular physiology

Advanced pharmaceutical bulletin

BioFactors (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Sepideh Maralbashi, Cynthia Aslan, Houman Kahroba, Milad Asadi, Mohammad Sadegh Soltani-Zangbar, Navideh Haghnavaz, Farhad Jadidi, Farhad Salari, Tohid Kazemi
Docosahexaenoic acid (DHA) impairs hypoxia-induced cellular and exosomal overexpression of immune-checkpoints and immunomodulatory molecules in different subtypes of breast cancer cells. BMC nutrition 10 (1) (2024)
Sepideh Maralbashi, Cynthia Aslan, Houman Kahroba, Milad Asadi, Mohammad Sadegh Soltani-Zangbar, Navideh Haghnavaz, Farhad Jadidi, Farhad Salari, Tohid Kazemi
Docosahexaenoic acid (DHA) impairs hypoxia-induced cellular and exosomal overexpression of immune-checkpoints and immunomodulatory molecules in different subtypes of breast cancer cells. BMC nutrition 10 (1) (2024)
Manouchehr Fadaee, Hajar Abbasi, Sepideh Maralbashi, Behzad Baradaran, Dariush Shanehbandi, Masood Faghih Dinevari, Tohid Kazemi
Docosahexaenoic acid may inhibit immune evasion of colorectal cancer cells through targeting immune checkpoint and immunomodulator genes and their controlling microRNAs. BioFactors (Oxford, England) 48 (5) (2022)
Seyed Ziaeddin Rasihashemi, Erfan Rezazadeh Gavgani, Reza Majidazar, Parya Seraji, Mobina Oladghaffari, Tohid Kazemi, Parisa Lotfinejad
Tumor-derived exosomal PD-L1 in progression of cancer and immunotherapy. Journal of cellular physiology (2021)
Mehdi Talebi, Hojjatollah Nozad Charoudeh, Ali Akbar Movassaghpour Akbari, Behzad Baradaran, Tohid Kazemi
Acellular Wharton's Jelly, Potentials in T-Cell Subtypes Differentiation, Activation and Proliferation. Advanced pharmaceutical bulletin 10 (4) (2020)
Nafiseh Paydarnia, Behzad Mansoori, Davoud Esmaeili, Tohid Kazemi, Mahyar Aghapour, Khalil Hajiasgharzadeh, Nazila Alizadeh, Behzad Baradaran
Helicobacter pylori Recombinant CagA Regulates Th1/Th2 Balance in a BALB/c Murine Model. Advanced pharmaceutical bulletin 10 (2) (2020)
Mehdi Talebi, Hojjatollah Nozad Charoudeh, Ali Akbar Movassaghpour Akbari, Behzad Baradaran, Tohid Kazemi
Effect of Cellular-Based Artificial Antigen Presenting Cells Expressing ICOSL, in T-cell Subtypes Differentiation and Activation. Advanced pharmaceutical bulletin 11 (3) (2020)
Behzad Mansoori, Ali Mohammadi, Morten Frier Gjerstorff, Solmaz Shirjang, Zahra Asadzadeh, Vahid Khaze Shahgoli, Uffe Holmskov, Tohid Kazemi, Pascal H G Duijf, Behzad Baradaran
miR-142-3p is a tumor suppressor that inhibits estrogen receptor expression in ER-positive breast cancer. Journal of cellular physiology (2019)
Behzad Mansoori, Ali Mohammadi, Zahra Asadzadeh, Solmaz Shirjang, Mahsa Minouei, Fereydoon Abedi-Gaballu, Neda Shajari, Tohid Kazemi, Morten Frier Gjerstorff, Pascal H G Duijf, Behzad Baradaran
HMGA2 and Bach-1 cooperate to promote breast cancer cell malignancy. Journal of cellular physiology 234 (10) (2019)
Behzad Mansoori, Ali Mohammadi, Mehri Ghasabi, Solmaz Shirjang, Razeieh Dehghan, Vahid Montazeri, Uffe Holmskov, Tohid Kazemi, Pascal H G Duijf, Morten Frier Gjerstorff, Behzad Baradaran
miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression. Journal of cellular physiology 234 (6) (2018)
Mahsa Javadian, Tohid Gharibi, Najibeh Shekari, Meghdad Abdollahpour-Alitappeh, Ali Mohammadi, Arezoo Hossieni, Hamed Mohammadi, Tohid Kazemi
The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis. Journal of cellular physiology 234 (5) (2018)